FDA approves EOS imaging online 3D spine surgery planning solution

Paris-based medical imaging company EOS imaging announced today that its spineEOS software—an online 3D tool for spine surgery planning—has received FDA approval.

The software allows surgeons to create treatment strategies from pelvic and vertebral 3D data resulting from an EOS exam, which can in turn be used to formulate a plan based on the exact shape and length of the spinal implants.

“We believe that patients’ spines are complex 3D systems that need a personalized 3D planning of the intended surgery,” said ESO imaging CEO, Marie Meynadier, in a press release. “We look forward to this next important step toward our broader goal of expanding our EOSapps planning software suite to better connect imaging to patient care.”

Approval of the software allows the company to continue its expansion into the growing U.S. spine market, which includes approximately 400,000 patients per year at an orthopedic implant value of $3 billion.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.